498 related articles for article (PubMed ID: 16538969)
21. Renal tubular proteinuria and microalbuminuria in diabetic patients.
Gibb DM; Tomlinson PA; Dalton NR; Turner C; Shah V; Barratt TM
Arch Dis Child; 1989 Jan; 64(1):129-34. PubMed ID: 2923463
[TBL] [Abstract][Full Text] [Related]
22. Prognostic Value of Tubulointerstitial Lesions, Urinary N-Acetyl-β-d-Glucosaminidase, and Urinary β2-Microglobulin in Patients with Type 2 Diabetes and Biopsy-Proven Diabetic Nephropathy.
Mise K; Hoshino J; Ueno T; Hazue R; Hasegawa J; Sekine A; Sumida K; Hiramatsu R; Hasegawa E; Yamanouchi M; Hayami N; Suwabe T; Sawa N; Fujii T; Hara S; Ohashi K; Takaichi K; Ubara Y
Clin J Am Soc Nephrol; 2016 Apr; 11(4):593-601. PubMed ID: 26801478
[TBL] [Abstract][Full Text] [Related]
23. Urinary N-acetyl-beta-glucosaminidase excretion is a marker of tubular cell dysfunction and a predictor of outcome in primary glomerulonephritis.
Bazzi C; Petrini C; Rizza V; Arrigo G; Napodano P; Paparella M; D'Amico G
Nephrol Dial Transplant; 2002 Nov; 17(11):1890-6. PubMed ID: 12401843
[TBL] [Abstract][Full Text] [Related]
24. Evaluation of high dose of perindopril/indapamide fixed combination in reducing blood pressure and improving end-organ protection in hypertensive patients.
Mourad JJ; Le Jeune S
Curr Med Res Opin; 2009 Sep; 25(9):2271-80. PubMed ID: 19627177
[TBL] [Abstract][Full Text] [Related]
25. Effects of a fixed combination of perindopril and indapamide in patients with type 2 diabetes and chronic kidney disease.
Heerspink HJ; Ninomiya T; Perkovic V; Woodward M; Zoungas S; Cass A; Cooper M; Grobbee DE; Mancia G; Mogensen CE; Neal B; Chalmers J;
Eur Heart J; 2010 Dec; 31(23):2888-96. PubMed ID: 20501479
[TBL] [Abstract][Full Text] [Related]
26. Persistence of the antihypertensive effect of low-dose combination therapy in mild hypertension.
Myers MG; Leenen FH;
Blood Press; 2006; 15(6):325-32. PubMed ID: 17472022
[TBL] [Abstract][Full Text] [Related]
27. Urinary N-acetyl-beta-D-glucosaminidase activity does not predict development of diabetic nephropathy.
Agardh CD; Tallroth G; Hultberg B
Diabetes Care; 1987; 10(5):604-6. PubMed ID: 3677979
[TBL] [Abstract][Full Text] [Related]
28. Blood pressure-lowering efficacy and safety of perindopril/indapamide/amlodipine single-pill combination in patients with uncontrolled essential hypertension: a multicenter, randomized, double-blind, controlled trial.
Mourad JJ; Amodeo C; de Champvallins M; Brzozowska-Villatte R; Asmar R;
J Hypertens; 2017 Jul; 35(7):1481-1495. PubMed ID: 28306636
[TBL] [Abstract][Full Text] [Related]
29. What can be learned from the experience with the fixed low-dose combination of perindopril/indapamide in the treatment of hypertension?
Waeber B
Expert Opin Pharmacother; 2005 Oct; 6(13):2291-9. PubMed ID: 16218889
[TBL] [Abstract][Full Text] [Related]
30. Efficacy of very low dose perindopril 2 mg/indapamide 0.625 mg combination on left ventricular hypertrophy in hypertensive patients: the P.I.C.X.E.L. study rationale and design.
Gosse P; Dubourg O; Guéret P; De Simone G; Schmieder R; De Leeuw PW; Degaute JP; García Puig J; Karpov Y; Magometschnigg D; Matos L; Amouyel P; Asmar R; Le Heuzey JY; Nieminen M; Dahlöf B
J Hum Hypertens; 2002 Sep; 16(9):653-9. PubMed ID: 12214263
[TBL] [Abstract][Full Text] [Related]
31. Urinary excretion of n-acetyl-beta-D-glucosaminidase and retinol binding protein as alternative indicators of nephropathy in patients with type 1 diabetes mellitus.
Salem MA; el-Habashy SA; Saeid OM; el-Tawil MM; Tawfik PH
Pediatr Diabetes; 2002 Mar; 3(1):37-41. PubMed ID: 15016173
[TBL] [Abstract][Full Text] [Related]
32. Urinary N-acetyl-β-D-glucosaminidase, an early marker of diabetic kidney disease, might reflect glucose excursion in patients with type 2 diabetes.
Kim SR; Lee YH; Lee SG; Kang ES; Cha BS; Kim JH; Lee BW
Medicine (Baltimore); 2016 Jul; 95(27):e4114. PubMed ID: 27399115
[TBL] [Abstract][Full Text] [Related]
33. Urinary excretion of beta-thromboglobulin and N-acetyl-beta-D-glucosaminidase in type 1 diabetes: potential indicators of early nephropathy?
Patrick AW; Oliver MD; Howie AF; Dawes J; Macintyre CC; Frier BM
Diabete Metab; 1990; 16(5):441-7. PubMed ID: 2150050
[TBL] [Abstract][Full Text] [Related]
34. Antihypertensive efficacy of triple combination perindopril/indapamide plus amlodipine in high-risk hypertensives: results of the PIANIST study (Perindopril-Indapamide plus AmlodipiNe in high rISk hyperTensive patients).
Tóth K;
Am J Cardiovasc Drugs; 2014 Apr; 14(2):137-45. PubMed ID: 24590580
[TBL] [Abstract][Full Text] [Related]
35. Equivalence of indapamide SR and enalapril on microalbuminuria reduction in hypertensive patients with type 2 diabetes: the NESTOR Study.
Marre M; Puig JG; Kokot F; Fernandez M; Jermendy G; Opie L; Moyseev V; Scheen A; Ionescu-Tirgoviste C; Saldanha MH; Halabe A; Williams B; Mion Júnior D; Ruiz M; Hermansen K; Tuomilehto J; Finizola B; Gallois Y; Amouyel P; Ollivier JP; Asmar R
J Hypertens; 2004 Aug; 22(8):1613-22. PubMed ID: 15257186
[TBL] [Abstract][Full Text] [Related]
36. Renal function, glycemic control and perindopril in diabetic patients.
Brichard S; Ketelslegers JM; Lambert AE
Clin Exp Hypertens A; 1989; 11 Suppl 2():545-54. PubMed ID: 2691128
[TBL] [Abstract][Full Text] [Related]
37. Effects of the angiotensin II type 1 receptor antagonist candesartan, compared with angiotensin-converting enzyme inhibitors, on the urinary excretion of albumin and type IV collagen in patients with diabetic nephropathy.
Sato A; Tabata M; Hayashi K; Saruta T
Clin Exp Nephrol; 2003 Sep; 7(3):215-20. PubMed ID: 14586718
[TBL] [Abstract][Full Text] [Related]
38. ADVANCE: breaking new ground in type 2 diabetes.
Chalmers J; Perkovic V; Joshi R; Patel A
J Hypertens Suppl; 2006 Aug; 24(5):S22-8. PubMed ID: 16936533
[TBL] [Abstract][Full Text] [Related]
39. Fixed low-dose perindopril-indapamide combination in hypertensive patients with chronic renal failure.
Meyrier A; Dratwa M; Sennesael J; Lachaud-Pettiti V
Am J Hypertens; 1998 Sep; 11(9):1087-92. PubMed ID: 9752894
[TBL] [Abstract][Full Text] [Related]
40. Urinary activities of cathepsin B, N-acetyl-beta-D-glucosaminidase, and albuminuria in patients with type 2 diabetes mellitus.
Piwowar A; Knapik-Kordecka M; Fus I; Warwas M
Med Sci Monit; 2006 May; 12(5):CR210-4. PubMed ID: 16641878
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]